Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 3/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL466295 | 0.87 | ALDH1A1 (0.56) | LMNAALDH1A1TSHRCYP1A2USP2 | |
| Hydrochloric Acid SCHEMBL6578159 | 0.85 | ALDH1A1 (0.55) | LMNAALDH1A1TSHRCYP1A2USP2 | |
| SCHEMBL6098963 | 0.83 | TSHR (0.36) | LMNAALDH1A1TSHRCYP1A2GAA | |
| SCHEMBL23007584 | 0.82 | ALDH1A1 (0.48) | LMNAALDH1A1TSHRCYP1A2USP2 | |
| SCHEMBL18573883 | 0.79 | CYP1A2 (0.44) | LMNAALDH1A1TSHRCYP1A2USP2 | |
| SCHEMBL6098958 | 0.78 | CYP1A2 (0.30) | CYP1A2 | |
| SCHEMBL4577419 | 0.77 | GAA (0.44) | LMNAALDH1A1TSHRCYP1A2USP2 | |
| SCHEMBL14060088 | 0.77 | LMNA (0.40) | LMNAALDH1A1TSHRCYP1A2USP2 | |
| SCHEMBL6575839 | 0.76 | ALDH1A1 (0.47) | LMNAALDH1A1TSHRCYP1A2USP2 | |
| SCHEMBL6367487 | 0.76 | ALDH1A1 (0.34) | LMNAALDH1A1TSHRGAAMGAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7037939-B2 | Compound and derivative of gabapentin | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUE (TW) | 2006-05-02 | — | — | US | disclosed |
| US-20040248811-A1 | Compound and derivative of gabapentin | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2004-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040248811-A1 | Compound and derivative of gabapentin | GABRA4, NPY4R, CNR2 | LMNA 2633/4885ALDH1A1 1596/4885TSHR 1412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.